Difference between revisions of "Cytokeratin 19"

From Libre Pathology
Jump to navigation Jump to search
(create)
 
Line 6: Line 6:
*Gastrointestinal tract.<ref name=pmid19956064/>
*Gastrointestinal tract.<ref name=pmid19956064/>
*Pancreas.<ref name=pmid19956064/>
*Pancreas.<ref name=pmid19956064/>
*[[Cholangiocarcinoma]].
*Salivary gland - marks luminal cells.
*[[Adamantinoma]].
*[[Yolk sac tumour]].<ref>{{Cite journal  | last1 = Bremmer | first1 = F. | last2 = Ströbel | first2 = P. | last3 = Hubertus | first3 = H. | last4 = Strecker | first4 = J. | last5 = Gaisa | first5 = N. | last6 = Strauß | first6 = A. | last7 = Schweyer | first7 = S. | last8 = Radzun | first8 = H-J. | last9 = Behnes | first9 = C-L | title = CK19 is a sensitive marker for yolk sac tumours of the testis. | journal = Diagnostic Pathology | volume = 10 | issue = 7 | pages = | month =  | year = 2015 | doi = 10.1186/s13000-015-0243-y | PMID =  | url = www.diagnosticpathology.org/content/10/1/7‎Cached }}</ref>
==Negative==
*[[Hepatocellular carcinoma]].


==See also==
==See also==
Line 12: Line 19:


==References==
==References==
{{Reflist|1}}
{{Reflist|2}}


[[Category:Immunohistochemistry]]
[[Category:Immunohistochemistry]]

Revision as of 21:33, 20 August 2015

Cytokeratin 19, abbreviated CK19, is a commonly available keratin.

Positive

Negative

See also

References

  1. 1.0 1.1 1.2 Jain, R.; Fischer, S.; Serra, S.; Chetty, R. (Jan 2010). "The use of Cytokeratin 19 (CK19) immunohistochemistry in lesions of the pancreas, gastrointestinal tract, and liver.". Appl Immunohistochem Mol Morphol 18 (1): 9-15. doi:10.1097/PAI.0b013e3181ad36ea. PMID 19956064.
  2. Bremmer, F.; Ströbel, P.; Hubertus, H.; Strecker, J.; Gaisa, N.; Strauß, A.; Schweyer, S.; Radzun, H-J. et al. (2015). [www.diagnosticpathology.org/content/10/1/7‎Cached "CK19 is a sensitive marker for yolk sac tumours of the testis."]. Diagnostic Pathology 10 (7). doi:10.1186/s13000-015-0243-y. www.diagnosticpathology.org/content/10/1/7‎Cached.